JP2005507892A5 - - Google Patents

Download PDF

Info

Publication number
JP2005507892A5
JP2005507892A5 JP2003530666A JP2003530666A JP2005507892A5 JP 2005507892 A5 JP2005507892 A5 JP 2005507892A5 JP 2003530666 A JP2003530666 A JP 2003530666A JP 2003530666 A JP2003530666 A JP 2003530666A JP 2005507892 A5 JP2005507892 A5 JP 2005507892A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
inflammation
composition according
treatment
disease associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003530666A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005507892A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/029673 external-priority patent/WO2003027075A2/en
Publication of JP2005507892A publication Critical patent/JP2005507892A/ja
Publication of JP2005507892A5 publication Critical patent/JP2005507892A5/ja
Pending legal-status Critical Current

Links

JP2003530666A 2001-09-19 2002-09-19 炎症の治療のための置換されたピラゾリルベンゼンスルファミド化合物 Pending JP2005507892A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32323001P 2001-09-19 2001-09-19
PCT/US2002/029673 WO2003027075A2 (en) 2001-09-19 2002-09-19 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation

Publications (2)

Publication Number Publication Date
JP2005507892A JP2005507892A (ja) 2005-03-24
JP2005507892A5 true JP2005507892A5 (https=) 2006-01-05

Family

ID=23258258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003530666A Pending JP2005507892A (ja) 2001-09-19 2002-09-19 炎症の治療のための置換されたピラゾリルベンゼンスルファミド化合物

Country Status (7)

Country Link
US (1) US6849653B2 (https=)
EP (1) EP1438293A2 (https=)
JP (1) JP2005507892A (https=)
BR (1) BR0212661A (https=)
CA (1) CA2461567C (https=)
MX (1) MXPA04002683A (https=)
WO (1) WO2003027075A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040092552A1 (en) * 2000-04-25 2004-05-13 Brown David L 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation
UA79804C2 (en) * 2002-07-03 2007-07-25 Janssen Pharmaceutica Nv Cck-1 receptor modulators
WO2004041285A1 (en) 2002-10-31 2004-05-21 Amgen Inc. Antiinflammation agents
EP1694686A1 (en) * 2003-12-19 2006-08-30 Takeda San Diego, Inc. Kinase inhibitors
US7276050B2 (en) * 2004-03-02 2007-10-02 Alan Franklin Trans-scleral drug delivery method and apparatus
US20050250829A1 (en) * 2004-04-23 2005-11-10 Takeda San Diego, Inc. Kinase inhibitors
AR050253A1 (es) 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
WO2006023931A2 (en) * 2004-08-18 2006-03-02 Takeda San Diego, Inc. Kinase inhibitors
PE20060748A1 (es) 2004-09-21 2006-10-01 Smithkline Beecham Corp Derivados de indolcarboxamida como inhibidores de quinasa ikk2
EP1812439B2 (en) * 2004-10-15 2017-12-06 Takeda Pharmaceutical Company Limited Kinase inhibitors
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
AR055343A1 (es) 2005-06-30 2007-08-22 Smithkline Beecham Corp Derivados de indolcarboxamida inhibidores de quinasas ikk2
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
AR058223A1 (es) * 2005-11-25 2008-01-23 Palau Pharma Sa Un comuesto de derivados de pirazoloisoquinolina, un procedimiento para l a preparacion de dicho compuesto y una composicion farmaceutica que comprende dicho compuesto
SG158147A1 (en) 2006-10-09 2010-01-29 Takeda Pharmaceutical Kinase inhibitors
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
WO2010102968A1 (en) 2009-03-10 2010-09-16 Glaxo Group Limited Indole derivatives as ikk2 inhibitors
WO2014055624A1 (en) 2012-10-02 2014-04-10 The General Hospital Corporation D/B/A Massachusetts General Hospital Methods relating to dna-sensing pathway related conditions
WO2015112792A1 (en) * 2014-01-24 2015-07-30 Abbvie Inc. Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
TWI831738B (zh) 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物
US11993574B2 (en) 2018-06-15 2024-05-28 Reata Pharmaceuticals, Inc Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma
US12060340B2 (en) 2018-06-20 2024-08-13 Reata Pharmaceuticals, Inc Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940418A (en) * 1972-04-07 1976-02-24 G. D. Searle & Co. Esters and amides of 4,5-dihydrobenz[g]indazole-3-carboxylic acids and related compounds
GB8814587D0 (en) 1988-06-20 1988-07-27 Erba Carlo Spa Condensed pyrazole 3-oxo-propanenitrile derivatives & process for their preparation
US5260328A (en) * 1989-04-06 1993-11-09 Farmitalia Carlo Erba Srl Phenyl-indenopurazol 3-oxo-propanamide derivatives useful in the treatment of rheumatoid arthritis
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2665898B1 (fr) 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5134155A (en) * 1991-08-08 1992-07-28 Ortho Pharmaceutical Corporation Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors
US5434178A (en) 1993-11-30 1995-07-18 G.D. Searle & Co. 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation
US5696143A (en) * 1994-09-20 1997-12-09 Talley; John J. Benz G! indazolyl derivatives for the treatment of inflammation
AU4006795A (en) 1994-11-10 1996-06-06 Olin Corporation Process for gas phase chlorine dioxide delignification
AU762992B2 (en) 1998-11-06 2003-07-10 Abbott Gmbh & Co. Kg Tricyclic pyrazole derivatives
PL350891A1 (en) * 1999-04-06 2003-02-10 Knoll Gmbh Substituted 1,4-dichlorindene[1,2-c]pyrazoles as inhibitors of tyrosine kinase

Similar Documents

Publication Publication Date Title
JP2005507892A5 (https=)
JP2003503454A5 (https=)
JP2006502236A5 (https=)
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
IL164373A (en) Benzamide derivatives, pharmaceutical compositions containing them, process for their preparation and use thereof in the manufacture of medicaments and as medicaments in the treatment of diseases associated with cancer
NO20090095L (no) Anvendelse av en hydrofil matriks omfattende et polyakrylsyrederivat, en cellulose-eter og et disintegreringsmiddel for fremstilling av et medikament for behandling av kvinners genitale forstyrrelser
JP2005500357A5 (https=)
RU2001128504A (ru) Композиции для стимулирования роста
EA200800538A1 (ru) Терапевтические соединения
JP2007536277A5 (https=)
WO2003073981A3 (en) Novel of cytokine inhibitors
WO2007012022A3 (en) Unit dose form with ibuprofen-famotidine admixture
JP2006514116A5 (https=)
SE0400184D0 (sv) New therapeutical use
JP2003526626A5 (https=)
JP2023545372A5 (https=)
JP2008513510A5 (https=)
EP1781277A4 (en) COMBINATION PREPARATION
JP2002542248A5 (https=)
JP2010500284A5 (https=)
EP1404281A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE IN THE TREATMENT OF SKIN AND / OR MOLECULAR INJURY; USE OF COMPOSITIONS IN THE TREATMENT OF SKIN AND / OR GLOBAL INJURY AND USE OF COMPOUNDS IN THE TREATMENT OF SKIN AND / OR GLARE INJURY
JP2005500277A5 (https=)
JP2006504735A5 (ja) 絨毛性性腺刺激ホルモンを含む慢性骨盤疼痛症候群の治療用組成物
JP2009516719A5 (https=)